Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2010
08/25/2010CN1972917B Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
08/25/2010CN101815712A Pyrazole compounds and their use as RAF inhibitors
08/25/2010CN101815711A Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
08/25/2010CN101815710A Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
08/25/2010CN101815704A Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1
08/25/2010CN101812056A A novel pyridine derivative substituted by alkyl acting as an reuptaking inhibitor for the monoamine neurotransmitter.
08/25/2010CN101812054A 1-acetyl-N-phenyl-N-(3-(4-(3-phenyl-1-H-pyrazole-5-radial)piperidine-1-radical)propyl)-4-amide derivative and preparation method thereof
08/25/2010CN101812053A Nitrogenous cotinine class derivate and preparation method thereof
08/25/2010CN101812052A Quinoline carboxylic acid derivative containing isatin substitute and preparation method thereof
08/25/2010CN101812051A High purity fasudil hydrochloride compound
08/25/2010CN101812050A Ortho-carbonyl benzamide pesticide
08/25/2010CN101812021A Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same
08/24/2010US7781596 Substituted 2-phenylbenzimidazoles, the production thereof and their use
08/24/2010US7781595 Benzimidazole derivatives: preparation and pharmaceutical applications
08/24/2010US7781591 Substituted 3-cyanopyridines as protein kinase inhibitors
08/24/2010US7781585 Crystalline forms of Gatifloxacin
08/24/2010US7781584 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
08/24/2010US7781457 Isoquinolinone potassium channel inhibitors
08/24/2010US7781456 The desired characteristics of chiral compounds helps reduce the toxicity of compound; to treat mood disorders, depression; pain, neurodegenerative disorders, sexual disorders, drug abuse etc.
08/24/2010US7781455 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; dipeptidylpeptidase-IV enzyme inhibitors; diabetes
08/24/2010US7781438 Prevent transplant rejection
08/24/2010US7781436 such as 1-Benzyl-2-methyl-1H-indol-3-yl)-(4-phenyl-piperidin-1-yl)-methanone, vasopressin (V1a) receptor antagonists, for the treatment of dysmenorrhea, hypertension, congestive heart failure, inappropriate secretion of vasopressin, cirrhosis, nephrosis, obsessive compulsive disorder and as anxiolytics
08/24/2010US7781430 Benzoxazole carboxamides for treating CINV and IBS-D
08/24/2010US7781426 cholesterol ester transfer protein (CETP) inhibitors such as (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[2-(3,3-dimethylpiperidin-1-yl)-5-(trifluoromethyl)benzyl]-4-methyl-1,3-oxazolidin-2-one, useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis
08/24/2010CA2570805C 2-(1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence
08/24/2010CA2490907C Amide derivative
08/24/2010CA2467857C Piperidine-based mch antagonists for treatment of obesity and cns disorders
08/24/2010CA2460135C Use of pyridazinone compounds as phosphodiesterase iv inhibitors for treating cancer and other diseases
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/19/2010WO2010093849A2 Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions
08/19/2010WO2010093845A1 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
08/19/2010WO2010093706A2 Chemically programmed vaccination
08/19/2010WO2010093605A1 Isotopologues of thalidomide
08/19/2010WO2010093595A1 Fungicidal 2-pyridones
08/19/2010WO2010093434A1 Isotopologues of lenalidomide
08/19/2010WO2010093419A1 Novel amino azaheterocyclic carboxamides
08/19/2010WO2010092966A1 Novel triazine derivative and pharmaceutical composition containing same
08/19/2010WO2010092962A1 Hetero ring derivative
08/19/2010WO2010092387A1 Process for preparation of bezoyl amino heterocyclyl compounds
08/19/2010WO2010092340A1 Fused pyridine and pyrazine derivatives as kinase inhibitors
08/19/2010WO2010092043A1 Phenoxy acetic acid derivatives
08/19/2010WO2010091721A1 3 -substituted 1-arylsulfonylpiperidine derivatives for the treatment of pain
08/19/2010WO2010091652A1 A method for the manufacture of (s) -5-methoxy-2- [ [ (4-methoxy-3, 5-dimethyl-2-pyrimidinyl) methyl] sulfinyl] -ih-benz imidazole using a chiral complex with lactic acid
08/19/2010WO2010074607A3 Active substance and pharmaceutical composition for treating alcohol dependence, and a method for obtaining and the use of said active substance
08/19/2010WO2010066028A8 3,4 - substituted piperidine derivatives as renin inhibitors
08/19/2010WO2010056656A3 Preparation of crystalline palonosetron hydrochloride
08/19/2010WO2010045276A3 Azabenzimidazolones
08/19/2010WO2009122034A8 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
08/19/2010US20100210848 Process for optically active sulfoxide compounds
08/19/2010US20100210847 Process for the preparation of pantoprazole sodium and pantoprazole sodium sesquihydrate
08/19/2010US20100210846 Process for preparing 2-(2-pyridylmethyl)-sulfinyl-1H-benzimidazoles and the intermediate compounds used therein
08/19/2010US20100210845 process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
08/19/2010US20100210838 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
08/19/2010US20100210836 Small molecule inhibitors of lymphoid tyrosine phosphatase
08/19/2010US20100210690 N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators
08/19/2010US20100210687 Compounds which have activity at M1 receptor and their uses in medicine
08/19/2010US20100210686 Therapeutic agents useful for treating pain
08/19/2010US20100210685 Novel Substituted Indoles
08/19/2010US20100210671 Quinazolinone T-Type Calcium Channel Antagonists
08/19/2010US20100210665 Diarylhydantoin compounds
08/19/2010US20100210664 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
08/19/2010US20100210661 Stat3/5 activation inhibitor
08/19/2010US20100210659 Pyrrolidine derivatives as nk3 receptor antagonists
08/19/2010US20100210657 Bicyclic Benzamides of 3-or 4-Substituted 4-(Aminomethyl)-Piperidine Derivatives
08/19/2010US20100210656 NOVEL sEH INHIBITORS AND THEIR USE
08/19/2010US20100210648 Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
08/19/2010US20100210637 Heteroaryloxy nitrogenous saturated heterocyclic derivative
08/19/2010US20100210635 Renin inhibitors
08/19/2010US20100210634 Certain Chemical Entities, Compositions and Methods
08/19/2010US20100210633 Carboxamide compounds and their use
08/19/2010US20100210632 Novel pyrrolinone derivative and pharmaceutical composition comprising the same
08/19/2010US20100210629 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
08/19/2010US20100210628 NOVEL sEH INHIBITORS AND THEIR USE
08/19/2010US20100210627 Pyrazine compounds, their use and methods of preparation
08/19/2010US20100210620 Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers
08/19/2010US20100210618 Piperidine/piperazine derivatives
08/19/2010US20100210617 Aryl-Alkylamines And Heteroaryl-Alkylamines As Protein Kinase Inhibitors
08/19/2010US20100210593 Pyridine- and Pyrimidinecarboxamides as CXCR2 Modulators
08/19/2010US20100210592 Amines or amino alcohols as glyt1 inhibitors
08/19/2010US20100210466 4-phenyl-pyrane-3,5-diones,4-phenyl-thiopyrane-3,6-diones and cyclohexanetriones as novel herbicides
08/19/2010US20100210036 Ppar active compounds
08/19/2010US20100209418 Solid Forms of a Raf Kinase Inhibitor
08/19/2010CA2755935A1 Hetero ring derivative
08/19/2010CA2752269A1 Novel triazine derivative and pharmaceutical composition comprising the same
08/19/2010CA2752190A1 Small molecule bradykinin b1 receptor antagonists
08/19/2010CA2751886A1 Novel amino azaheterocyclic carboxamides
08/19/2010CA2751260A1 Phenoxy acetic acid derivatives
08/18/2010EP2218717A1 Fungicidal N-((HET)Arylethyl)thiocarboxamide derivatives
08/18/2010EP2217596A2 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
08/18/2010EP2217590A1 Pyridopyrimidine derivatives as pi3 kinase inhibitors
08/18/2010EP2217589A2 Modulators of ocular oxidative stress
08/18/2010EP2217580A2 Substituted tetrazole compounds and uses thereof
08/18/2010EP2217572A1 Isoquinoline modulators of atp-binding cassette transporters
08/18/2010EP2217569A1 Enantioselective process for preparing a substituted alkanoic acid
08/18/2010EP2217568A1 Compounds for inhibiting ksp kinesin activity
08/18/2010EP2217565A1 Compounds which modulate the cb2 receptor
08/18/2010EP2076495B1 Quinoline derivatives with 5-ht-binding properties
08/18/2010EP1984350B1 Pyrimidine derivatives used as pi-3 kinase inhibitors
08/18/2010EP1758857B1 Indole derivatives as antiviral agents
08/18/2010EP1737842B1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
1 ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 ... 1080